Bosutinib

Category: Cancer



Bosutinib Overview

Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer. Contents 1 Mechanism 2 Medical uses 3 Contraindications 4 Interactions 5 Notes 6 See also 7 References 8 External links Mechanism It is an ATP-competitive Bcr-Abl tyrosine-kinase inhibitor with an additional inhibitory effect...

Read more Bosutinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bosutinib

Recent Bosutinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bosutinib
  • Tablet: 100mg, 400mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Bosutinib or a similar ingredient: (1 result)